Humana (HUM) Long-Term Investments (2009 - 2026)

Humana (HUM) has 18 years of Long-Term Investments data on file, last reported at $626.0 million in Q1 2026.

• On a quarterly basis, Long-Term Investments rose 62.18% year-over-year to $626.0 million in Q1 2026; TTM through Mar 2026 was $626.0 million, a 62.18% increase from a year earlier, with the FY2025 full-year figure at $493.0 million, up 53.11% from the prior year.
• Long-Term Investments for Q1 2026 stood at $626.0 million, up from $493.0 million in the prior quarter.
• Over the last five years, Long-Term Investments for HUM reached as high as $13.5 billion in Q1 2022 and fell as low as $174.0 million in Q2 2022.
• Historically, Long-Term Investments has averaged $1.2 billion across 5 years, with a median of $386.0 million in 2025.
• Across the five-year window, Long-Term Investments sank 98.81% in 2022 and surged 321.26% in 2023, its largest moves.
• Year by year, Long-Term Investments stood at $749.0 million in 2022, then plunged by 70.89% to $218.0 million in 2023, then jumped by 47.71% to $322.0 million in 2024, then surged by 53.11% to $493.0 million in 2025, then advanced by 26.98% to $626.0 million in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $626.0 million in Q1 2026, $493.0 million in Q4 2025, and $440.0 million in Q3 2025.